Owing to the highest CXCR2 mRNA expression in the de novo DLBCL and tFL lymphoma subtypes compared with GC-B, an immunohistochemical analysis of this chemokine receptor was performed. The gene discussed is CXCR2; the disease is diffuse large B-cell lymphoma.